News
2d
PsyPost on MSNALS breakthrough: Ashwagandha-derived drug shows promise in slowing progression of amyotrophic lateral sclerosisEvery year roughly 1,000 Canadians are diagnosed with amyotrophic lateral sclerosis (ALS, also known as Lou Gehrig’s disease). Some 4,000 Canadians are currently living with the disease. There are few ...
The company has partnered with Nvidia to develop “cognitive AI,” which it says will allow people with severe physical disabilities to have more natural interactions with the world around them.
Rodney Gorham, who has amyotrophic lateral sclerosis (ALS ... "We are building a brain foundation model using generative pre-training techniques that learn directly from neural data ...
They administered an oral dose of NU-9 to a mouse model of Alzheimer's disease and found the animals' performance on memory tests improved. In promising follow-up studies, the team also found NU-9 ...
Mr Gorham has amyotrophic lateral sclerosis ... “We are building a brain foundation model using generative pre-training techniques that learn directly from neural data — abstracting human ...
Background Lateral ankle sprains (LAS ... Patients with CAI experience persistent ankle dysfunctions and detrimental long-term sequelae. Brain-level adaptations could explain these undesirable ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results